Incyte
INCY
#1110
Rank
A$30.30 B
Marketcap
A$154.34
Share price
2.05%
Change (1 day)
32.88%
Change (1 year)

Incyte (INCY) - Cash on Hand

Cash on Hand as of September 2025 : A$4.41 Billion

According to Incyte's latest financial reports the company has A$4.41 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Incyte - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$3.46 B-35.34%
2023-12-31A$5.36 B12.74%
2022-12-31A$4.75 B46.95%
2021-12-31A$3.23 B38.26%
2020-12-31A$2.34 B-22.54%
2019-12-31A$3.02 B48.14%
2018-12-31A$2.04 B36.28%
2017-12-31A$1.49 B33.57%
2016-12-31A$1.12 B15.45%
2015-12-31A$0.97 B32.46%
2014-12-31A$0.73 B28.53%
2013-12-31A$0.57 B159.62%
2012-12-31A$0.21 B-18.81%
2011-12-31A$0.27 B-35.17%
2010-12-31A$0.41 B-20.26%
2009-12-31A$0.52 B86.57%
2008-12-31A$0.28 B-4.3%
2007-12-31A$0.29 B-27.42%
2006-12-31A$0.40 B-14.28%
2005-12-31A$0.47 B-22.33%
2004-12-31A$0.60 B53.58%
2003-12-31A$0.39 B-48.09%
2002-12-31A$0.76 B-23.49%
2001-12-31A$0.99 B-4.42%
2000-12-31A$1.04 B922.77%
1999-12-31A$0.10 B-43.94%
1998-12-31A$0.18 B112.8%
1997-12-31A$85.34 M792.04%
1996-12-31A$9.56 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
A$14.21 B 222.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.01 B-76.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$14.92 B 238.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$22.55 B 411.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A$0.57 B-87.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.36 B-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$14.68 B 232.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
A$0.11 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
A$88.84 M-97.99%๐Ÿ‡บ๐Ÿ‡ธ USA